Sofimac Innovation

Sofimac Innovation, originally known as iSource, is a French venture capital firm established in 1998 and located in Paris. The firm specializes in early-stage investments, focusing on minority stakes primarily in seed and early-stage companies. Sofimac Innovation has a diverse investment portfolio, targeting sectors such as software, life sciences, engineering sciences, cleantech, and manufacturing across Western Europe. In August 2021, the firm was acquired by UI Investissement, marking a significant transition in its operational structure while continuing its commitment to fostering innovation in various industries.

Philippe Vuagnat Ph.D

Associate Director

20 past transactions

Nestwave

Venture Round in 2021
Nestwave SAS, founded in 2014 and headquartered in Paris, France, specializes in developing advanced geolocation systems tailored for the Internet of Things (IoT) sector. The company provides innovative solutions that enhance localization accuracy and reliability, particularly in challenging indoor and densely populated urban environments. Utilizing patented hybrid-signal technology, Nestwave's offerings significantly reduce power consumption and the overall footprint of geolocation solutions, making them more efficient compared to traditional methods. By targeting IoT modem and digital signal processing (DSP) vendors, Nestwave aims to integrate its cutting-edge geolocation capabilities within their platforms, thereby improving user experience and operational efficiency in various applications.

GLIMPS

Series A in 2021
GLIMPS is a developer of artificial intelligence-powered cyber security software that identifies malware and threats. GLIMPS' next-generation scanning platform and investigation automation address the most sophisticated threats effectively. The GLIMPS technology is intended to read and comprehend the binary elements. This technology enables binary analysis and threat detection to be automated in the blink of an eye.

AcuSurgical

Series A in 2021
AcuSurgical is a startup focused on advancing vitreo-retinal surgery through innovative technology. The company is developing a robotic surgical assistant specifically designed for retinal microsurgery, which aims to enhance the precision of eye operations. By providing surgeons with improved tools, AcuSurgical's device addresses common challenges faced in the treatment of retinal diseases, such as age-related macular degeneration. The technology helps filter hand tremors and enhances visualization during procedures, ultimately enabling better patient outcomes in the field of ophthalmic surgery.

Stirweld

Seed Round in 2021
Stirweld is a company specializing in the development of advanced friction stir welding (FSW) technologies tailored for various industrial sectors. The firm provides a range of products and services, including industrial friction welding machines, clamping systems, and prototyping solutions. Additionally, Stirweld offers training and expert consultation to facilitate the adoption of FSW techniques across multiple industries, including automotive, aerospace, space, and metalworking. By enabling the integration of friction stir welding into all computer numerical control machine tools, Stirweld aims to enhance manufacturing processes and improve overall efficiency for its clients.

ELWAVE

Venture Round in 2021
ELWAVE is a manufacturer of electromagnetic detection systems for underwater and industrial robotics. It was created in 2018 to promote more than 10 years of research work by the biorobotics laboratory of the Institut Mines-Telecom Atlantique on “electric sense” technology. The “electric sense” is a mode of perception used by tropical fish living in muddy, heavily congested waters with branches in which vision and acoustics are ineffective. Natural evolution has led these fish to acquire this alternative mode of perception adapted to their environment.

Antaios

Series A in 2020
Antaios is a technology company focused on developing innovative memory solutions aimed at addressing the challenges associated with advanced computing. By leveraging the spin-orbit torque phenomenon, Antaios creates memory technology that combines high speed with non-volatility, effectively tackling the increasing power demands faced by chip manufacturers in advanced semiconductor systems. This technology enables clients to enhance the performance of computers and smartphones while maintaining low power consumption, thus optimizing energy efficiency in modern electronic devices. Antaios is dedicated to bringing its groundbreaking technology to market, contributing to the evolution of memory solutions in the technology sector.

Vulkam

Series A in 2020
Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, specializing in the design and production of amorphous metal parts. Founded in 2017, Vulkam focuses on creating biocompatible amorphous metal alloys primarily composed of zirconium, copper, hafnium, nickel, and titanium. The company's innovative products serve various industries, including aerospace, automotive, biomedical, and microcomponents. Vulkam's micromechanical parts are notable for their small size and exceptional strength, offering performance comparable to established industry standards. By leveraging advanced materials science, Vulkam aims to set new benchmarks in metallurgy and metal processing, catering to the growing demand for high-performance, functional components in diverse applications.

Beekast

Series A in 2020
Beekast is a company specializing in interactive meeting management software designed to enhance online meetings and training sessions. The platform offers user-friendly tools for creating, leading, and tracking these events, making it suitable for both in-person and remote work environments. Beekast enables users to engage their audience with digital activities such as word clouds, surveys, and boards directly integrated into slides. This software is designed to facilitate collaboration, gather feedback, and interact with participants effectively, whether the context is workshops, virtual meetings, or conferences.

Diabeloop

Series B in 2019
Diabeloop is a medical device company based in Grenoble, France, specializing in innovative solutions for diabetes management. Founded in 2015, the company focuses on developing a closed-loop system that automates insulin delivery for individuals with type 1 diabetes. Its AI-based blood sugar monitoring device integrates a sensor that continuously measures glucose levels, a pump that administers insulin, and a smartphone application that connects these components through an embedded algorithm. This technology aims to enhance the treatment experience by reducing the mental burden on patients, allowing them to manage their condition more effortlessly and live their lives with greater freedom.

Zionexa

Private Equity Round in 2019
Zionexa is a global company focused on the development and commercialization of in-vivo biomarkers aimed at guiding targeted therapies in oncology. By leveraging advanced molecular imaging technology, Zionexa provides physicians with clear and detailed images that enhance the diagnosis of metastatic breast cancer. This innovative approach allows for the early identification of tumors and facilitates personalized patient care, improving the treatment pathway and overall quality of life for cancer patients. Through its commitment to advancing diagnostic capabilities, Zionexa plays a significant role in the evolving landscape of personalized medicine in oncology.

Nestwave

Venture Round in 2019
Nestwave SAS, founded in 2014 and headquartered in Paris, France, specializes in developing advanced geolocation systems tailored for the Internet of Things (IoT) sector. The company provides innovative solutions that enhance localization accuracy and reliability, particularly in challenging indoor and densely populated urban environments. Utilizing patented hybrid-signal technology, Nestwave's offerings significantly reduce power consumption and the overall footprint of geolocation solutions, making them more efficient compared to traditional methods. By targeting IoT modem and digital signal processing (DSP) vendors, Nestwave aims to integrate its cutting-edge geolocation capabilities within their platforms, thereby improving user experience and operational efficiency in various applications.

Igyxos Biotherapeutics

Series A in 2019
Igyxos Biotherapeutics is a French company focused on developing pharmaceuticals and medical technologies to enhance human fertility. Established in 2017 and based in Nouzilly, Igyxos is dedicated to addressing the global demand for improved infertility solutions for both men and women. The company engages in all phases of drug development, from discovering promising biological targets to identifying lead compounds, including small molecules and monoclonal antibodies. These compounds are designed to interact with gonadotropins and hormones crucial for reproduction, thereby improving fertility treatments. Additionally, Igyxos supports the progression of potential drug candidates through pre-clinical and clinical development stages, while also acquiring intellectual property rights related to its innovative products and technologies.

Primo1D

Venture Round in 2019
Primo1D, established in 2013 and based at MINATEC Campus in Grenoble, France, specializes in embedding intelligence into objects and materials using its proprietary E-Thread® yarn technology. This yarn contains electronics that enable companies to trace and monitor their products for anti-theft and anti-counterfeiting purposes, thereby enhancing product value.

Cardiawave

Venture Round in 2018
Cardiawave is a medical technology company established in 2014 through a collaboration between the Langevin Institute, renowned for its expertise in ultrasound imaging and therapy, and the Georges Pompidou European Hospital, which specializes in valve disease and cardiac ultrasound imaging. The company focuses on developing a non-invasive ultrasonic device aimed at treating heart valve diseases, particularly calcified aortic stenosis. This innovative device employs real-time image guidance and ultrasound technology to provide effective treatment without causing thermal injury, facilitating quicker procedures and enhancing the likelihood of successful outcomes for patients. With an experienced management team, Cardiawave has raised over €14 million to advance its product development and conduct preclinical studies, with the goal of initiating first-in-man trials.

ISORG

Series B in 2018
Isorg SA, founded in 2010 and based in Grenoble, France, specializes in the development and manufacturing of organic and printed electronic devices, particularly in the fields of photonics and image sensors. The company is noted for its innovative high-performance opto-electronic sensors, which can be integrated into various products, transforming surfaces made of plastic or glass into smart interfaces. Isorg offers a comprehensive range of services, from proof-of-concept to mass production, catering to diverse applications across consumer electronics, home appliances, smart buildings, industrial sectors, healthcare, and safety. Additionally, the company provides support for product development and integration. Its technology includes large-area image sensors and photodetectors, contributing to sectors such as medical imaging, non-destructive testing, and data security.

Cosmo Tech

Series B in 2018
Cosmo Tech is a global technology company founded in 2010 by Michel Morvan and Hugues de Bantel, based in Lyon, France. Originally known as The CoSMo Company, it specializes in modeling and simulating complex systems across various industries. The company's innovative software transforms raw data into organized knowledge, enabling clients to gain clear insights and run simulations on multiple scenarios to evaluate decision outcomes. This capability supports C-suite executives in making optimal business decisions in complex environments. Over the years, Cosmo Tech has garnered industry recognition, including accolades from Gartner and EY, and has expanded its operations to North America, establishing a presence in San Francisco. With a diverse team of over 70 employees, the company continues to serve clients in both Europe and North America.

Exeliom

Series A in 2018
Exeliom is a clinical-stage biopharmaceutical company based in Dijon, France, focused on developing innovative microbial therapies that utilize commensal bacteria as therapeutic agents. Founded in 2016, Exeliom aims to unlock the therapeutic potential of gut microbiota to enhance health and longevity. The company specializes in creating a new class of medicines known as Live Biotherapeutics, which are designed to deliver microbiome-based immunotherapy for conditions such as inflammatory bowel diseases and cancer, with an initial focus on Crohn's Disease. By harnessing the role of microbiota in the immune system, Exeliom strives to provide patients with advanced treatments that improve their quality of life.

eLichens

Venture Round in 2018
eLichens is a company focused on providing detailed information about air quality through innovative technology. It develops a comprehensive air quality analysis and prediction application that utilizes low-power micro gas sensors and connected stations. These systems are capable of detecting, monitoring, and predicting air quality for both indoor and outdoor environments. By combining its portfolio of patents and expertise, eLichens serves a range of clients, including industries, smart cities, and consumers, helping them enhance local air quality. The company operates offices in Grenoble, France, and Silicon Valley, California, reflecting its commitment to advancing air quality solutions in various markets.

Cintoo

Venture Round in 2017
Cintoo is a technology company focused on managing and utilizing 3D data derived from Reality Capture devices in the cloud. It has developed a unique point cloud-to-surface technology that converts data from terrestrial laser scanners into a versatile and collaborative format known as Reality Data. This innovative technology is integrated into Cintoo Cloud, a cloud-based platform that is compatible with various laser scanning hardware and Building Information Modeling (BIM) systems. By bridging the gap between reality capture and digital twins, Cintoo's platform enhances efficiency for companies in the construction industry, facilitating improved planning and management of buildings and infrastructure.

Adloop

Seed Round in 2017
Adloop is a media optimization platform focused on enhancing the performance of digital marketing initiatives. The company specializes in collecting and standardizing various types of marketing data, utilizing algorithmic attribution to analyze consumer behavior. By providing insights and recommendations, Adloop enables marketing managers and online advertisers to measure the effectiveness of their branding and conversion campaigns. This approach facilitates better collaboration among marketing teams and agencies, allowing them to understand the impact of their marketing efforts on target customers and make informed adjustments to their strategies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.